🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Isomorphic Labs CTO, Sergei Yakneen, will be participating at the Festival of Genomics & Biodata on Thursday 30.01.25. Catch him on the Data Driven Drug Discovery Stage at 12.20 for a talk delving into how Isomorphic Labs is advancing rational drug design. He will also join

We are excited to announce the expansion of our collaboration with Novartis, doubling the number of research programs just over a year after initiating our partnership. This expansion is testament to the great progress we’ve made together and further unlocks the potential to

In parallel with @isomorphiclabs and Novartis announcing the expansion of our research collaboration, IsoLabs Chief AI Officer, Max Jaderberg , Novartis CEO Vas Narasimhan and Vineeta Agarwala came together for a fascinating panel discussion at the PhRMA Forum in Washington, D.C.

Our Chief Technology Officer, Sergei Yakneen participated in an insightful panel discussion on the start of the TechBio Revolution, alongside Lindsey Edwards, Maureen Makes and Nerida Scott, moderated by @LukeTimmerman. Exciting conversations shaping the future of biotech!

Our expanded collaboration with Novartis is a testament to the progress and potential of our work in reimagining drug discovery. Read more from Demis Hassabis in the full announcement here: isomorphiclabs.com/articles/isomo… #AI #drugdiscovery #machinelearning

Our expanded collaboration with Novartis further unlocks the potential of combined expertise, data, and technological capabilities to accelerate our work and continue our progress towards shared drug discovery goals. Read more from Fiona Marshall in the full announcement here:

Our Chief Technology Officer, Sergei Yakneen, and Chief AI Officer, Max Jaderberg, will be at NVIDIA GTC to share more about how we’re using powerful AI models including AlphaFold 3 in our work to reimagine drug discovery. Join them at 10am PT on 20th March, find out more about

Our General Counsel & Head of Business Operations, Sarah Korman, will be discussing the future of AI in healthcare at Goodwin’s Annual Healthcare & Life Sciences Summit in London at 4.50pm on 27th March. You can register your interest now: bit.ly/4hInoNu

Our Chief Technology Officer, Sergei Yakneen, and Chief AI Officer, Max Jaderberg, took the stage at #NVIDIAGTC to discuss how we are applying and developing AI models, including AlphaFold 3 to rationally design therapeutics at Isomorphic Labs. Log in to watch the full session

Meet us at ICLR 2025! We’ll be in Singapore from April 23, come interview for our open roles at Isomorphic Labs. Register here: rsvp.withgoogle.com/events/isomorp… #ICLR2025

This week we announced our first external funding round of $600 million, led by Thrive Capital with participation from GV and our existing investor, Alphabet. Find out more here: bit.ly/42cnRlg

Join our Chief Technology Officer, Sergei Yakneen , at Google Cloud Next on 10 April at 10.45am PDT, where he will be sharing more about our work at Isomorphic Labs including further developing a next-generation unified AI drug design engine, built on GCP. #GoogleCloudNext

If you are attending Google Cloud Next don’t miss our CTO Sergei Yakneen speaking on a panel, From Code to Cure: AI for biotech startups at 2.45 PDT on Thursday, 10 April. You can also catch Sergei’s presentation on AI-powered drug design at 10.45 PDT on the same day. Register

“The future of biology won’t be siloed—it will be collaborative, interdisciplinary, and deeply creative. Demis is helping us get there faster.” We’re thrilled to see our CEO, Demis Hassabis, recognised as one of TIME’s 100 Most Influential People in the world. In this feature,

Here’s what Isomorphic Labs has planned for #ICLR2025. Don’t miss your chance to connect with us in Singapore! Fast track hiring - Interview with us and you could receive an offer on the spot! (23/04) Live talk - Michael & Agnieszka share the latest on Isomorphic Labs (24/04,

“We’re building generalisable AI models capable of learning from the entire universe of protein and chemical interactions. This fundamentally breaks from the target-specific, siloed approach of conventional drug development.” Tune in to hear our Chief Technology Officer,

An insightful day at our London office yesterday! We were thrilled to host Prof Sir Mene Pangalos FRS, a distinguished member of our Scientific Advisory Board. Our Chief Scientific Officer, Miles Congreve, led a fascinating fireside chat with Sir Mene, diving into crucial topics like selecting the

It was a fantastic week at ICLR with insightful conversations and the opportunity to meet so many brilliant people. A big thank you to everyone who stopped by to chat, attend our sessions, or learn more about what we’re building at Isomorphic Labs. Over the week, we fast-tracked

We’re hiring at MLSys 2025! Isomorphic Labs is reimagining drug discovery with the power of AI, and we’re building a world-class MLOps team to do it. Join us as a Machine Learning Performance Engineer to help scale our cutting-edge models that will shape the future of human